【Notice】Regarding Fraudulent Communications Impersonating Our Company and Its Personnel
【Notice】 Regarding Fraudulent Communications Impersonating Our Company and Its Personnel
> Get to Know Us
> Our Products
> Product Safety
> About Us
> Research&Development
> Sustainability
> Domestic Self-Medication Operations
> International Business
> Prescription Pharmaceutical Operations
> View More
2026/07/07
Notice Regarding Fraudulent Communications Impersonating Our Company and Its Personnel
2025/09/18
Notice Regarding Counterfeit "Pabron Gold A" Cold Medicine